Stereotaxis Stock Market Outlook
| STXS Stock | USD 1.90 -0.02 -1.04% |
Stereotaxis' sentiment score summarizes the balance between positive and negative signals in recent news and social media and is used here as a behavioral input rather than as a trading instruction. About 62% of recent sentiment around Stereotaxis has been slightly more constructive than defensive over the recent sample. Taken on its own, that leaves the current sentiment reading for Stereotaxis slightly above neutral currently.
Investor Comfort Level
PanicConfidence
62 · Interested
Elasticity to Hype and News Sentiment
Stereotaxis news sentiment reading of 73% (positive) tracks how media and analyst commentary are framing the investment case. Shifts in news tone at this level often precede a change in trading character that warrants attention.
Given a 90-day horizon, with a moderate risk tolerance, the model output for Stereotaxis is 'Strong Sell'. The Stereotaxis buy-or-sell recommendation is derived from the selected investment horizon and risk tolerance parameters for Stereotaxis.
Stereotaxis |
Run Stereotaxis Outlook Model
The Stereotaxis model signal complements the current analyst consensus on Stereotaxis. Macroaxis holds no financial interest in Stereotaxis or in any other asset this module covers.
How This Model Works
The recommendation output for Stereotaxis is a model-based view that converts the selected horizon and risk profile into a standardized reading of the current evidence.
- Inputs - valuation signals, price behavior, volatility, liquidity, sentiment, and analyst coverage when available
- Current setup - Three Months with a risk setting described as I am an average risk taker
- Limits - the model does not account for taxes, outside holdings, concentration constraints, or investor-specific mandates
Use the output as structured decision support and pair it with your own research, portfolio context, and any professional advice you rely on.
Time Horizon
Risk Tolerance
Strong Sell
Market Performance | Weak | Details | |
Volatility | Stable | Details | |
Current Valuation | Below Model Estimate | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Shows low sensitivity to market movements | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Stereotaxis' current outlook reflects a cautious setup, where negative margins limit earnings-based valuation support, while contained volatility and intact fundamental quality provide partial offset. The model's 'Strong Sell' signal reflects persistent headwinds that outweigh the offsetting factors in the model. For the selected horizon, Stereotaxis yields Mean Deviation of 2.26, Standard Deviation of 2.75, and Variance of 7.56, which weigh on the current risk-reward outlook.The model output for Stereotaxis integrates risk-adjusted performance, valuation signals, and the current expert consensus into a single quantitative reading. For additional context on this micro-cap stock in the Health Care sector, review the full set of Stereotaxis reported fundamentals, including the relationship between the net income ttm and number of employees. Given Stereotaxis' price to earnings ttm reading, its fundamentals and Probability Of Bankruptcy provide additional context for this model output.
Recent Events and Market Context
The events below reflect recent headlines associated with Stereotaxis. Not all items directly affect the outlook — they are included to show the broader information environment that can shape sentiment and trading behavior.
Returns Distribution Density
This chart shows how Stereotaxis' daily returns have been spread out over time. It gives a quick sense of what outcomes are most likely for Stereotaxis.
| Mean Return | -0.17 | Value At Risk | -4.76 | Potential Upside | 4.43 | Standard Deviation | 2.75 |
Return Density |
| Distribution |
Good risk management means knowing how likely big price swings are. The return distribution chart shows this clearly for Stereotaxis.
Key Drivers of Volatility and Market Exposure
Stereotaxis is exposed to both systematic and unsystematic risk. Systematic risk reflects broader stock market movements, while company or sector-specific developments represent nonmarket drivers. Diversification may reduce specific risk, but market exposure remains. Beta and standard deviation help quantify volatility. Stereotaxis's financial profile includes a Mean Deviation of 2.26, an Option Implied Volatility of 1.92, and a Standard Deviation of 2.75.
α | Alpha over Dow Jones | -0.1816 | |
β | Beta against Dow Jones | -0.4001 | |
σ | Overall volatility | 2.59 | |
Ir | Information ratio | -0.0649 |
Fundamentals Vs Peers
Stereotaxis' fundamentals tested against peer averages expose where the stock leads, lags, or diverges from its group. Revenue growth, margin structure, and return on capital at Stereotaxis are tested against the same metrics at comparable stocks.
| Better Than Average | Worse Than Average | Compare Stereotaxis to competition |
Note: Acquisition by Kimberly Peery of 40000 shares of Stereotaxis at 1.87 subject to Rule 16 b-3 [view details]
Market Momentum
Beta of -0.4001 dampens broad market moves. Stereotaxis strength readings help frame whether the current move is gaining support or losing conviction. The company operates within the Healthcare sector and the Medical Instruments & Supplies industry. Stereotaxis momentum view improves when strength data is validated against the fundamental trend.
Recommendation Framework, Assumptions & Editorial Oversight
The model output for Stereotaxis reflects the current horizon and risk settings, refreshes as underlying data changes, and is intended to organize evidence rather than replace investor judgment. Current model inputs for Stereotaxis include P/E of 21.61, ROE of -143.56%. External analyst coverage is currently summarized as Strong Buy across 4 analysts, but it is treated here as a secondary reference input rather than a stand-alone recommendation. Published target-price assumptions may also be reviewed when available, but they can change quickly as analyst models are revised. 
Stereotaxis data is compiled from periodic company reporting and market reference feeds and standardized for comparability. The model combines valuation, price behavior, volatility, and sentiment into a standardized quantitative view.
Editorial Review & Methodology Oversight
Role: Member of Macroaxis Editorial Board
Finance background: Ellen covers public companies in North America, focusing primarily on valuation and volatility. Six years of experience in predictive investment analytics and risk management.
Oversight scope: Reviews recommendation-framework framing, source assumptions, and disclosure language.